naltrexone has been researched along with Canine Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Joo, H; KuKanich, B; KuKanich, K; Locuson, CW; Rankin, DC | 1 |
| Berke, K; Cho, P; Comroe, A; Crauer, B; Fitzgerald, AH; Gonzalez, SE; Jensen, G; Klocke, EE; Komp, M; KuKanich, B; KuKanich, K; Mason, D; Orchard, R; Rankin, DC; Upchurch, DA | 1 |
| Cho, P; Fitzgerald, AH; Komp, MS; KuKanich, B; KuKanich, K; Locuson, CW; Rankin, DC | 1 |
| Chen, T; Powell, CC | 1 |
| Schwartz, S | 1 |
| White, SD | 1 |
| Court, MH; Dixon, R; Dodman, NH; Parker, D; Shuster, L; White, SD | 1 |
2 trial(s) available for naltrexone and Canine Diseases
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Fluconazole; Methadone; Naltrexone; Opioid-Related Disorders | 2020 |
Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
Topics: Administration, Ophthalmic; Animals; Cornea; Dog Diseases; Dogs; Double-Blind Method; Female; Keratoconjunctivitis Sicca; Male; Naltrexone; Tears | 2015 |
5 other study(ies) available for naltrexone and Canine Diseases
| Article | Year |
|---|---|
Perioperative analgesia associated with oral administration of a novel methadone-fluconazole-naltrexone formulation in dogs undergoing routine ovariohysterectomy.
Topics: Administration, Oral; Analgesia; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Female; Fluconazole; Humans; Hysterectomy; Methadone; Naltrexone; Ovariectomy; Pain, Postoperative | 2020 |
Multiple-dose pharmacokinetics and opioid effects of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs.
Topics: Administration, Oral; Analgesics; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Fluconazole; Humans; Methadone; Naltrexone; Opioid-Related Disorders | 2021 |
Naltrexone-induced pruritus in a dog with tail-chasing behavior.
Topics: Animals; Behavior, Animal; Dog Diseases; Dogs; Male; Naltrexone; Pruritus; Self Mutilation; Stereotyped Behavior | 1993 |
Naltrexone for treatment of acral lick dermatitis in dogs.
Topics: Animals; Dermatitis; Dog Diseases; Dogs; Drug Evaluation; Erythromycin; Female; Male; Naltrexone; Parakeratosis; Recurrence | 1990 |
Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs.
Topics: Animals; Behavior, Animal; Dog Diseases; Dogs; Injections, Subcutaneous; Naltrexone; Narcotic Antagonists; Pruritus | 1988 |